{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:41:08Z","timestamp":1776206468854,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Hospitals Authority Talent Training Plan","award":["QMS20191701"],"award-info":[{"award-number":["QMS20191701"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We aimed to describe the characteristics and outcomes in pregnant women with liver cirrhosis, and identify the predictors of adverse events of mother and fetus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospectively collected mothers with liver cirrhosis in our center from 6\/2010 to 6\/2019. Women without liver cirrhosis were selected as a control in a 1:2 ratio. The primary assessment was the frequency of maternal and fetal adverse events. The secondary assessment was the adverse events in patients continuing pregnancy or not and the factors to predict the severe adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 126 pregnancies enrolled, 29 pregnancies were terminated for worrying disease progression and 97 pregnancies continued. One hundred ninety-four pregnancies without liver cirrhosis were selected as control. At baseline, patients with liver cirrhosis have a lower level of platelet, hemoglobin, prothrombin activity, and a higher level of ALT, total Bilirubin, creatinine. Compared to control, patients with liver cirrhosis had a higher frequency of adverse events, including bleeding gums (7.2%vs. 1.0%), TBA elevation (18.6%vs.3.1%), infection (10.3%vs.0.5%), cesarean section (73.6%vs.49.5%), postpartum hemorrhage (13.8% vs 2.1%), blood transfusion (28.9% vs 2.1%), new ascites or aggravating ascites (6.2% vs.0%), MODS (7.2% vs.0.5%) and intensive care unit admissions (24.1% vs 1.1%). The incidence of severe maternal adverse events was also higher (32.0% vs 1.5%). Women who chose to terminated the pregnancy had less severe adverse events (3.4% vs.32.0%).<\/jats:p>\n                    <jats:p>\n                      A higher frequency of fetal\/infants\u2019 complications was observed in liver cirrhosis population than control, including newborn asphyxia (10.2% vs1.1%), low birth weight infant (13.6% vs. 2.6%). In patients who progressed into the third trimester, multivariable regression analysis demonstrated that severe adverse events were associated with a higher CTP score (OR 2.128, 95% CI [1.002, 4.521],\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.049). Wilson\u2019s disease related liver cirrhosis has a better prognosis (OR\u2009=\u20090.009, 95% CI [0, 0.763],\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.038).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The incidence of the adverse events was significantly increased in pregnancies complicated by cirrhosis. The predictor of severe adverse events is higher CTP score. Wilson\u2019s disease induced liver cirrhosis have a better prognosis. Timely termination of pregnancy during the first trimester may avoid the incidence of severe adverse events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-021-03756-y","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T13:02:58Z","timestamp":1617886978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Maternal and fetal outcomes of patients with liver cirrhosis: a case-control study"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiang","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4628-8826","authenticated-orcid":false,"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"issue":"9615","key":"3756_CR1","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371(9615):838\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(08)60383-9.","journal-title":"Lancet"},{"issue":"4","key":"3756_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1530\/eje.0.1320444","volume":"132","author":"H Bell","year":"1995","unstructured":"Bell H, Raknerud N, Falch JA, Haug E. Inappropriately low levels of gonadotrophins in amenorrhoeic women with alcoholic and non-alcoholic cirrhosis. Eur J Endocrinol. 1995;132(4):444\u20139. https:\/\/doi.org\/10.1530\/eje.0.1320444.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"3756_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1478-3231.2009.02153.x","volume":"30","author":"AA Shaheen","year":"2010","unstructured":"Shaheen AA, Myers RP. The outcomes of pregnancy in patients with cirrhosis: a population-based study. Liver Int. 2010;30(2):275\u201383. https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02153.x.","journal-title":"Liver Int"},{"issue":"8","key":"3756_CR4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/lt.21572","volume":"14","author":"J Tan","year":"2008","unstructured":"Tan J, Surti B, Saab S. Pregnancy and cirrhosis. Liver Transpl. 2008;14(8):1081\u201391. https:\/\/doi.org\/10.1002\/lt.21572.","journal-title":"Liver Transpl"},{"issue":"11","key":"3756_CR5","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/hep4.1255","volume":"2","author":"H Hagstr\u00f6m","year":"2018","unstructured":"Hagstr\u00f6m H, H\u00f6ijer J, Marschall HU, Williamson C, Heneghan MA, Westbrook RH, et al. Outcomes of pregnancy in mothers with cirrhosis: a National Population-Based Cohort Study of 1.3 million pregnancies. Hepatol Commun. 2018;2(11):1299\u2013305. https:\/\/doi.org\/10.1002\/hep4.1255.","journal-title":"Hepatol Commun"},{"issue":"5 Pt 2","key":"3756_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/s0029-7844(99)00438-x","volume":"94","author":"GG Zeeman","year":"1999","unstructured":"Zeeman GG, Moise KJ Jr. Prophylactic banding of severe esophageal varices associated with liver cirrhosis in pregnancy. Obstet Gynecol. 1999;94(5 Pt 2):842. https:\/\/doi.org\/10.1016\/s0029-7844(99)00438-x.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"3756_CR7","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/AOG.0000000000002055","volume":"129","author":"A Palatnik","year":"2017","unstructured":"Palatnik A, Rinella ME. Medical and obstetric complications among pregnant women with liver cirrhosis. Obstet Gynecol. 2017;129(6):1118\u201323. https:\/\/doi.org\/10.1097\/AOG.0000000000002055.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"3756_CR8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/14767058.2015.1009438","volume":"29","author":"A Puljic","year":"2016","unstructured":"Puljic A, Salati J, Doss A, Caughey AB. Outcomes of pregnancies complicated by liver cirrhosis, portal hypertension, or esophageal varices. J Matern Fetal Neonatal Med. 2016;29(3):506\u20139. https:\/\/doi.org\/10.3109\/14767058.2015.1009438.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"3756_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijgo.2012.12.020","volume":"121","author":"SM Rasheed","year":"2013","unstructured":"Rasheed SM, Abdel Monem AM, Abd Ellah AH, Abdel Fattah MS. Prognosis and determinants of pregnancy outcome among patients with post-hepatitis liver cirrhosis. Int J Gynaecol Obstet. 2013;121(3):247\u201351. https:\/\/doi.org\/10.1016\/j.ijgo.2012.12.020.","journal-title":"Int J Gynaecol Obstet"},{"key":"3756_CR10","doi-asserted-by":"publisher","unstructured":"Kotzev AI, Tanchev LS, Pavlov CS, Tanchev SY. Unsolved issues of pregnancy in liver cirrhosis. Ter Arkh. 2019.15;91(4):114\u20137. https:\/\/doi.org\/10.26442\/00403660.2019.04.000145.","DOI":"10.26442\/00403660.2019.04.000145"},{"key":"3756_CR11","doi-asserted-by":"publisher","first-page":"bcr2017223076","DOI":"10.1136\/bcr-2017-223076","volume":"2018","author":"FJ Lelei-Mailu","year":"2018","unstructured":"Lelei-Mailu FJ, Mariara CM. Pregnancy in a patient with portal hypertension secondary to liver cirrhosis. BMJ Case Rep. 2018;2018:bcr2017223076.","journal-title":"BMJ Case Rep"},{"issue":"12","key":"3756_CR12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.cgh.2009.08.008","volume":"7","author":"SK Murthy","year":"2009","unstructured":"Murthy SK, Heathcote EJ, Nguyen GC. Impact of cirrhosis and liver transplant on maternal health during labor and delivery. Clin Gastroenterol Hepatol. 2009;7(12):1367\u20131372.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"3756_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/hep.22130","volume":"47","author":"JE Hay","year":"2008","unstructured":"Hay JE. Liver disease in pregnancy. Hepatology. 2008;47(3):1067\u201376. https:\/\/doi.org\/10.1002\/hep.22130.","journal-title":"Hepatology"},{"issue":"4","key":"3756_CR14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/hep.29490","volume":"67","author":"J Pfeiffenberger","year":"2018","unstructured":"Pfeiffenberger J, Beinhardt S, Gotthardt DN, Haag N, Freissmuth C, Reuner U, et al. Pregnancy in Wilson's disease: management and outcome. Hepatology. 2018;67(4):1261\u20139. https:\/\/doi.org\/10.1002\/hep.29490.","journal-title":"Hepatology"},{"key":"3756_CR15","doi-asserted-by":"publisher","first-page":"101668","DOI":"10.1016\/j.bpg.2020.101668","volume":"44\u201345","author":"S Mili\u0107","year":"2020","unstructured":"Mili\u0107 S, Tatalovi\u0107 T, Mikola\u0161evi\u0107 I. Pre-existing liver disease in pregnancy: Cirrhosis, autoimmune hepatitis and liver transplantation. Best Pract Res Clin Gastroenterol. 2020;44\u201345:101668.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"3756_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41395-018-0181-x","volume":"114","author":"ES Gonsalkorala","year":"2019","unstructured":"Gonsalkorala ES, Cannon MD, Lim TY, Penna L, Willliamson C, Heneghan MA. Non-invasive markers (ALBI and APRI) predict pregnancy outcomes in women with chronic liver disease. Am J Gastroenterol. 2019;114(2):267\u201375. https:\/\/doi.org\/10.1038\/s41395-018-0181-x.","journal-title":"Am J Gastroenterol"}],"updated-by":[{"DOI":"10.1186\/s12884-021-03823-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000}}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03756-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-03756-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03756-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T14:20:31Z","timestamp":1627654831000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-03756-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3756"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-03756-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-56781\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"assertion":[{"value":"8 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12884-021-03823-4","URL":"https:\/\/doi.org\/10.1186\/s12884-021-03823-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and with the 1964 Helsinki declaration and its later amendments. The study design was reviewed and approved by the Ethics Committee of Beijing YouAn Hospital, Capital Medical University (approval number: Jing-you-ke-lun-zi [2020]050-hao). Permission to access and to use these data was approved by the institution. The need for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"280"}}